5000872026-05-132026-05-135000872026-05-135000872026-05-13

ChangeInManagementDomain1

5000872026-05-132026-05-13

ChangeInManagementDomain1

5000872026-05-13

ChangeInManagementDomain2

5000872026-05-132026-05-13

ChangeInManagementDomain2

xbrli:pure

CIPLA

CIPLA LIMITED

500087

NOTLISTED

INE059A01026

true

Listed Entity (self)

true

2026-05-13

09:45:00

13:00:00

Mr Sushrut Kulkarni has been appointed as President & Global Chief – Integrated Product Development, member of Management Council and Senior Management Personnel in a full time employment. Hence column Term of Appointment in months is not applicable. He will retire upon attainment of 60 years of age.

2026-05-13

Appointment

Auditors

Cost Auditors

M/s.

Joshi Apte & Associates

2026-04-01

M/s Joshi Apte & Associates is a firm of Practicing Cost Accounts. The firm was established 16 years back by experienced, like-minded professionals and is serving the clients since 2009. They offer services in the domain of Cost and Management Accounting and beyond. The core strength of the firm lies in its team, which is a perfect blend of seasoned experts and dynamic young professionals. This combination enables the firm to deliver services with the highest level of professionalism. M/s Joshi Apte & Associates is committed to providing value addition to its clients through a dedicated and meticulous approach.

Appointment

Senior Management Personnel

President & Global Chief – Integrated Product Development

Mr.

Sushrut Kulkarni

2026-05-18

Mr Sushrut Kulkarni has been appointed as President & Global Chief – Integrated Product Development (IPD) at Cipla Limited and is also a member of the Company’s Management Council. Prior to joining Cipla, Sushrut served as the Global Head – Integrated Product Development Organization (IPDO) and a member of the Management Council at Dr Reddy’s Laboratories. Over the course of his three‑decade‑long career, he has held senior leadership roles with Glenmark & Zydus Lifesciences. Earlier in his career, he has also held positions of responsibility at Torrent Research Centre, Sandoz India, and Rhone Poulenc (India) Limited. With a strong track record of multiple filings and approvals across regulated and semi‑regulated markets across diverse dosage forms, Sushrut has consistently demonstrated the ability to scale R&D operations, unlock stalled pipelines, and successfully execute complex programs in highly regulated markets. Sushrut holds a Bachelor’s & Master’s degree in Pharmacy from Shivaji University & University of Mumbai respectively. Outside of work, he enjoys reading on history, autobiographies, and spirituality, and is passionate about fitness, writing, photography, and driving.